Group C patients showed a significant reduction of EFS and an almost significant decrease in OS compared to patients of group A; the therapeutic response of group B and C patients was similar [ 80 ].
← all excerpts
Genetic, Phenotypic, and Clinical Heterogeneity of NPM1-Mutant Acute Myeloid Leukemias.
1
—
—